EVAg

Human metapneumovirus A1:NL/1/00

Human metapneumovirus A2:NL/17/00

Human metapneuvirus B1:NL/99/1

Human metapneumovirus B2:NL/94/1

Human Immunodeficiency Virus (HIV) drug resistance remains a significant health issue that challenges treatment and prevention. The objective of this 3-week course is to learn bioinformatics techniques for the analysis of next-generation HIV sequencing results. This covers both HIV-1 and HIV-2. Teaching objectives include data curation, alignment, phylogenetics for typing, identification of drug resistance mutations, production of a resistance score, and interpretation. This course does not include genotyping itself, only sequence analysis and interpretation, as described above.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1.4. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1.19. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

We offer a 5 day training session to colleagues from endemic regions. Participants will visit the Viroscience clinical virology lab, where they will perform all required laboratory and analysis procedures for the quantification rabies virus and neutralizing antibodies.

hRSV type B

hRSV type A

hRSV type A

hRSV type A

hRSV type A

hRSV type A

hRSV type A

hRSV type A

Infectious cell culture supernatant

P1 cultured virus from a monkey pox positive patient. First Dutch isolate from MPXV infected patient. NOTE: This material is not available for commercial purposes, such as contract research services”

DNA isolated from cultured virus from a monkey pox positive patient. An unit contains 50ul isolated DNA (Ct value in realtime orthopox PCR approximately 25 when using 5 ul ). NOTE: This material is not available for commercial purposes, such as contract research services”

Human monoclonal recombinant IgG1 targeting the S2 domain of SARS-CoV-2 Spike as determined by ELISA.

Human monoclonal recombinant IgG1 targeting the S1 domain of SARS-CoV-2 Spike as determined by ELISA.

Human monoclonal recombinant IgG1 targeting the S1 domain of SARS-CoV-2 Spike domain of the wild type strain, as determined by ELISA.

Human monoclonal recombinant IgG1 targeting the S2 domain of SARS-CoV-2 Spike as determined by ELISA